13D Filing: Kim D Blickenstaff and Tandem Diabetes Care Inc (NASDAQ:TNDM)

---

CUSIP No. 875372 104		13D		Page 7 of 10 Pages

All percentages in this Item 5 relating to beneficial ownership of Common Stock are based on
49,836,070 shares of Common Stock issued and outstanding as of March 28, 2017, as reported by the Issuer to the Reporting Persons.

(b)

Regarding the number of shares as to which each Reporting Person has:

i.

sole power to vote or direct the vote: See line 7 of the applicable cover sheets for such Reporting Person.

ii.

shared power to vote or to direct the vote: See line 8 of the applicable cover sheets for such Reporting Person.

iii.

sole power to dispose or to direct the disposition: See line 9 of the applicable cover sheets for such Reporting Person.

iv.

shared power to dispose or direct the disposition: See line 10 of the applicable cover sheets for such Reporting Person.

(c)

None.

(d)

Not applicable.

(e)

Not applicable.

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

The outstanding option table in Item 6 of the Previously Amended Schedule 13D is hereby amended and restated in its entirety to read as follows:

The following table summarizes the terms of all outstanding options that Issuer has granted to Mr. Blickenstaff pursuant to the Issuers 2006 Stock
Incentive Plan or the Issuers 2013 Stock Incentive Plan.

Type of Option

Grant Date

Number of Securities Underlying Options (#)

Option Exercise Price ($)

Vesting Schedule

Option Expiration Date

Incentive Stock Option

4/23/2013

60,486

$

1.1059

Shares vest in 24 equal monthly installments beginning on May 23, 2013.

4/23/2023

Nonqualified Stock Option

4/23/2013

514,232

$

1.1059

Shares vest in 24 equal monthly installments beginning on May 23, 2013.

4/23/2023

Incentive Stock Option

11/13/2013

13,332

$

15.00

Shares vest as to 25% on 11/13/2014 and the remainder in 36 equal monthly installments.

11/13/2023